MGMT and central nervous system cancer: Across all 92 glioma cases, microscopy along with immunohistochemistry and O6-methylguanine-DNA-methyltransferase (MGMT) pyrosequencing was sufficient for a final, integrative diagnosis in 45 cases (49% of the total glioma subset).